Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

计划入组 51 人 · 首次发布于 2017 年 12 月 19 日

FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector

计划入组 10 人 · 首次发布于 2017 年 11 月 24 日

Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1

计划入组 13 人 · 首次发布于 2016 年 10 月 12 日

Fanc-A gene therapy (Genethon)

Fanc-A gene therapy(Généthon)

Fanc-A gene therapy (Fanconi anemia)

FANCL CORPORATION

Japan

SRIDHAR FANCY & READYMEDS

India

Whole-Genome Sequencing Algorithm Outperforms Standard Tests for Predicting PARP Inhibitor Response

UNCOVERseq Sets New Benchmark for CRISPR Off-Target Detection with 97.6% Sensitivity